Publications
Chernew ME, Gibson TB, Yu-Isenberg K, Sokol MC, Rosen AB, and Fendrick AM. Effects of Increased Patient Cost Sharing on Socioeconomic Disparities in Health Care. J Gen Intern Med 2008 23(8):1131–6 (PDF)
Chernew ME, Newhouse JP. What Does the RAND Health Insurance Experiment Tell Us About the Impact of Patient Cost Sharing on Health Outcomes? Am J Manag Care. July 2008; 14:412-414. (PDF)
M Chernew and AM Fendrick. Value and Increased Cost Sharing in the American Health Care System. Health Serv Res 1 Apr 2008 43(2): p. 451 (PDF)
Pan F, Chernew ME, Fendrick AM. Impact of Fixed-Dose Combination Drugs on Adherence to Prescription Medications. J Gen Intern Med 21 Feb 2008 (PDF)
Chernew ME, Shah MR, Wegh A, Rosenberg SN,Juster IA, Rosen AB, Sokol MC, Yu-Isenberg K, Fendrick AM. Impact Of Decreasing Copayments On Medication Adherence Within A Disease Management Environment. Health Affairs, 2008: 27; 103-112.
David A. Wells, MSc; Joseph S. Ross, MD, MHS; Allan S. Detsky, MD, PhD. What Is Different About the Market for Health Care? JAMA. 2007;298(23):2785-2787 (PDF)
Goldman DP, Joyce GF, Zheng Y. Prescription Drug Cost Sharing. JAMA, July 4, 2007; 298, No. 1; 61-27 (PDF)
Denny CC, Emanuel EJ, and Pearson SD. Why Well-Insured Patients Should Demand Value-Based Insurance Benefits. JAMA, June 13, 2007; 297, No. 22; 2515-2518 (PDF)
Fendrick, AM and Chernew, ME. "Fiscally Responsible, Clinically Sensitive" Cost Sharing: Contain Costs While PReserving Quality. Am J Manag Care. June 2007; 13:325-327. (PDF)
Chernew, ME, Fendrick, AM. The Business Case for Comparative Effectiveness Research. "Learning What Works Best. The Nation's Need for Evidence on Comparative Effectiveness in Health Care." Institute of Medicine. March, 2007. Appendix Seven: 1-13. (PDF)
View Full Report
Fendrick, AM and Chernew, ME. Value-Based Insurance Design: A "Clinically Sensitive, Fiscally Responsible" Approach to Mitigate The Adverse Clinical Effects of High-Deductible Consumer-Directed Health Plans. Society of General Internal Medicine. 2007;22:890-91 (PDF)
Braithwaite RS, Rosen AB. Linking Cost Sharing to Value: An Unrivaled Yet Unrealized Public Health Opportunity. Ann Intern Med 2007;146 602-605 (PDF)
Chernew, ME, Rosen, AB and Fendrick, AM. Value-Based Insurance Design: By abandoning the archaic principle that all services must cost the same for all patients, we can move to a high-value health system.
Health Aff. published 30 January 2007, 10.1377/hlthaff.26.2.w195. (PDF)
Fendrick AM, Chernew ME. Value-based Insurance Design:
Aligning Incentives to Bridge the Divide Between
Quality Improvement and Cost Containment. AM J Manag Care. 2006; 12:1-7. (PDF)
Rosen, AB. Grounding coverage in value: A paradigm for quality and costs. Medical Care. May 2006. (PDF)
Chernew ME, Rosen, AB, Fendrick AM, . Rising out-of-pocket costs in disease management programs. Am J Manag Care. 2006; 3:150-154. (PDF)
Fendrick AM, Chernew ME. Value-based insurance design: A "clinically sensitive"
approach to preserve quality and contain costs. Am J Manag Care. 2006; 1:18-20. (PDF)
Rosen AB, Hamel MB, Weinstein MC, Cutler D, Fendrick AM, Vijan S. Cost effectiveness of full Medicare coverage of angiotensin-converting enzyme inhibitors for beneficiaries with diabetes. Annals of Int Med. 2005;143:89-99. (PDF)
Ellis JJ et al. Suboptimal Stain Adherence and Discontinuation in Primary and Secondary Prevention Populations. J Gen Intern Med. 2004; 19:638-645. (PDF)
Fendrick AM, Smith DG, Chernew ME, Shah SN. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. Am J
Manag Care. 2001; 7:861-867. " (PDF)
